Reaxa Expects Indian Market to Push its Growth

Catalyst technologies company Reaxa (Manchester, U.K.), whose customers mainly include pharmaceutical and fine chemicals manufacturers, says that it expects India to become a major market for the company in the next 12 months. “The Indian pharmaceutical market is the most dynamic one as more drug products are coming off patent and several Indian pharma manufacturers are producing the generic versions of these drugs. This provides a great opportunity for Reaxa to get our technology to these new manufacturers,” Peter Jackson, CEO of Reaxa told CW at the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers